Cardiac tissue engineering holds great promise for the treatment of myocardial infarction. However, insufficient cell migration into the scaffolds used and inflammatory reactions due to scaffold biodegradation remain as issues to be addressed. Engineered heart tissue (EHT) grafts fabricated by means of a cell encapsulation technique provide cells with a tissue-like environment, thereby potentially enhancing cellular processes such as migration, proliferation, and differentiation, and tissue regeneration. This paper presents a study on the fabrication and characterization of EHT grafts from novel alginate/collagen composite microbeads by means of cell encapsulation. Specifically, the microbeads were fabricated from alginate and collagen by barium ion cross-linking, with neonatal rat cardiomyocytes encapsulated in the composite microbeads during the fabrication of the EHT grafts. To evaluate the suitablity of these EHT grafts for heart muscle repair, the growth of cardiac cells in the microbeads was examined by means of confocal microscopy and staining with DAPI and F-actin. The EHT grafts were analyzed by scanning electron microscopy and transmission electron microscopy, and the contractile function of the EHT grafts monitored using a digital video camera at different time points. The results show the proliferation of cardiac cells in the microbeads and formation of interconnected multilayer heart-like tissues, the presence of well-organized and dense cell structures, the presence of intercalated discs and spaced Z lines, and the spontaneous synchronized contractility of EHT grafts (at a rate of 20-30 beats min −1 after two weeks in culture). Taken together, these observations demonstrate that the novel alginate/collagen composite microbeads can provide a tissue-like microenvironment for cardiomyocytes that is suitable for fabricating native heart-like tissues.
Introduction
Myocardial infarction (MI) and subsequent heart failure are the leading causes of morbidity and mortality. Cellular therapy for cardiac repair, or the use of cells to improve cardiac function, has been extensively investigated. Two strategies have recently been developed for cellular transplantation, including in situ cellular cardiomyoplasty and implantation of engineered heart tissue (EHT). In the in situ cellular cardiomyoplasty strategy, cells of various origins are delivered into the infarcted myocardium; this has included neonatal cardiomyocytes [1] , skeletal myoblasts [2, 3] , embryonic stem cells [4] [5] [6] [7] , endothelial cells and/or progenitors [8] , adult mesenchymal cells [9] , bone marrow-derived cells [10, 11] , adipose stem cells [12, 13] , and induced pluripotent stem cells (iPS) [14] . Promising results have been obtained in many cases with varying improvement in cardiac performance. However, this strategy is limited in terms of low cell retention [15] , survival of the engrafted cells [16] [17] [18] , cell differentiation [19] , and integration of transplanted cells with host tissues. EHT implantation is an alternative strategy in which EHTs are grafted ex vivo and used to replace diseased or damaged myocardia or reconstruct cardiac malformations. Threedimensional (3D) cultures of neonatal and adult cardiac myocytes in artificial scaffolds have been developed to engineer functional micro-tissues [20] [21] [22] for the investigation of vasculature and perfusion in cultured myocardium [23] and the repair of damaged myocardium [24] . Leor et al [25] report that bioengineered heart grafts using porous alginate scaffolds attenuated left ventricular dilatation and heart function deterioration in a MI model. Zimmermann et al engineered 3D heart tissue by gelling a mixture of cardiomyocytes and collagen solution [26] . Engelmayr et al [27] report accordion-like honeycomb scaffolds that could promote the formation of grafts with preferentially aligned neonatal rat heart cells and with mechanical properties close to those of adult rat right ventricular myocardium. Although the EHT provides a direct source of contractile grafts to repair damaged myocardium, the development of these systems has been far from adequate; insufficient cell migration into scaffolds and inflammatory reactions due to scaffold biodegradation remain to be addressed [28, 29] . Cells in native myocardial tissue are considerably denser than those in other tissues. In myocardial tissue engineering, biodegradable scaffolds themselves tend to attenuate cell-tocell interconnections. Scaffold biodegradation then leads to fibrous tissues containing excessive amounts of extracellular matrix (ECM), which is observed in pathological states including ischemic heart disease or dilated cardiomyopathy [30] . To avoid the use of any additional materials, such as carrier substrates or scaffolds, Shimizu and colleagues [31] developed a novel approach of culturing cell sheets without scaffolds using a temperature-sensitive polymer; however, several cell sheets are required to create thicker grafts [32] .
EHTs grafted by means of cell encapsulation provide cells with a 3D tissue-like environment, thereby facilitating the maintenance of normal cellular function for tissue regeneration [33] . Microcapsules surrounding membranes are amenable to nutrient diffusion and molecules, such as oxygen and growth factors essential for cell survival [34] . Alginates are naturally existing polysaccharides that have been widely used in various biomedical applications [35] due to their biocompatibility and low toxicity [36] . The major drawbacks of alginates are their low cell-adhesiveness and poor support of cell proliferation. In contrast, collagen, a major component of ECM, has the ability to promote cell attachment and migration [37] ; thus, it is conceivable that collagen-containing microcarriers are suitable for cultivating the adherent cells. In this study, collagen was strategically combined with alginate to create composite microbeads. Cardiomyocytes were then encapsulated in the microbeads to fabricate EHTs.
Materials and methods
The preparation of materials for experiments presented in this paper was carried out under the protocol approved by the Harbin Institute of Technology's Animal Care and Use Committee.
Primary culture of neonatal rat cardiomyocytes
Ventricles from Wistar rats (1-3 days old; Harbin Medical University, China) were minced into 1-3 mm 3 fragments and incubated in a 50 mg mL −1 trypsin solution overnight. Samples were transferred into a trypsin inhibitor and warmed to 37
• C in a water bath, and then digested with collagenase for 45-60 min. The collagenase-digested samples were centrifuged at 1200 rpm for 5 min, filtered through a 100 μm mesh, and allowed to settle for 20 min at room temperature. Cardiomyocytes were suspended in culture medium (DMEM/F12 with HEPES, 5% horse serum, 1% antibiotic/antimycotic solution supplemented by 3 mM pyruvic acid, 2 g L −1 bovine serum albumin, 100 mg mL
ampicillin, 4 mg mL −1 transferrin, 0.7 ng mL −1 sodium selenite, 5 mg mL −1 linoleic acid, 100 mM ascorbic acid) at 37
• C in a humidified atmosphere containing 5% CO 2 . The purity of the cardiomyocyte suspension was evaluated by immunofluorescence staining with an anti-sarcomeric antibody.
Preparation of composite microbeads and cardiomyocyte encapsulation
Alginate/collagen barium composite microspheres for cardiomyocyte cultures were prepared by a non-contact, high potentiometric dispersion device custom made in our lab. Briefly, a 1.2% solution of low viscosity sodium alginate (Sigma) in 155 mM sodium chloride and 0.5% collagen (prepared from rat tail as previously reported [38] ) was prepared by stirring for several hours. The solution obtained was then sterilized by membrane filtration (0.22 μm pore size) and then mixed with previously pelleted cardiomyocytes at a cell density such that each microbead with a diameter of 1000 μm created below was entrapped with approximately 40 000 cells. Drops of the cell suspension in alginate/collagen were gently delivered using a 22-gauge needle to a gelling bath containing an isosmotic solution of barium chloride (BaCl 2 , 50 mM). The periphery of the alginate droplets gelled once in contact with the barium chloride. By adjusting the electric field voltage, beads could be created with diameters varying from 200 to 3000 μm. In the present study, beads with a diameter of 1000 μm, each entrapping about 40 000 cells, were chosen for use in the following cell growth tests. After a period of 10 min to allow for gel stabilization, the beads were washed four times with ten volumes of 155 mM barium chloride and then with culture medium. Cultures were incubated at 37
• C in a humidified atmosphere of 5% CO 2 in air. The nutrient medium was changed daily at a rate of 1 mL medium/day/10 6 cardiomyocytes.
Study on the cardiomyocyte growth in microbeads
Cardiomyocyte growth in the microbeads was monitored by cell F-actin and nuclei staining. Following fixation with 4% paraformaldehyde, the EHT grafts were stained with a 1:20 dilution of phalloidin-FITC (Sigma) for 2 h and counterstained with 2 mg mL −1 4 ,6 -diamidino-2-phenylindole hydrochloride (DAPI) (Sigma) for 2 min. Cardiomyocyte purity of the EHTs was confirmed by immunofluorescence staining with antibody of sarcomeric α-actin (Sigma) and ati-troponin T-c (Santa Cruz). Images were captured with a digital camera in a Nikon fluorescence microscope.
The beads were also embedded in wax and cut into 5 μm slices. These slices were then stained with the hematoxylin-eosin (H&E), and immunofluorescence with antibody focal adhesion kinases (FAKs, Santa Cruz) and anti-fibronectin (Beijing Biosynthesis Biotechnology Co.) in order to detect the focal adhesion formation and ECM protein synthesis. Images were captured by means of a laser confocal microscope.
The contractility of the EHT was captured on digital video and the beating rate counted at different time points.
SEM study
The structure of the microbeads, once lyophilized, was examined by scanning electron microscopy (SEM). Alginate beads were dissolved at room temperature for 15-20 min with ten volumes of an isosmotic solution of 55 mM sodium citrate and 90 mM sodium chloride (pH 7.8).
The EHT grafts were released from the microbeads and fixed with a solution containing 2% glutaraldehyde and 3% formaldehyde in cacodylate buffer (0.1 M cacodylate, 0.09 M sucrose, 0.01 M MgCl 2 , and 0.01 M CaCl 2 , pH 6.9) for 1 h. The samples were then dehydrated with a graded series of acetone (10%, 30%, 50%, 70%, 90%, and 100%) on ice, each lasting 15 min, followed by critical-point drying with liquid CO 2 . Samples were sputter coated with a gold film of approximately 10 nm thickness before analysis by SEM (Quanta 200 F, FEI Company, the Netherlands).
Ultrastructure study
EHT grafts were released from the microbeads and immediately fixed with cold 2% glutaraldehyde. After 24 h fixation at 4
• C, the samples were post-fixed with 1% osmium tetroxide for 1 h and dehydrated with varying concentrations of alcohol (50%, 70%, 80%, 90%, and 100%; three times at each concentration) for 10 min each. Next, EHT grafts were infiltrated with propylene oxide for 15 min, followed by 1:1 propylene oxide:epoxy resin for 4 h. Ultrathin sections were stained with uranyl acetate and lead citrate and examined by transmission electron microscopy (TEM) (JEM-1230, Tokyo, Japan).
Results
The alginate/collagen barium composite microspheres were fabricated with diameters varying from 200 to 3000 μm by controlling the voltage applied to the dispersion device. As an example, figures 1(A) and (B) show the images of beads with a diameter of 200 and 1000 μm, respectively. Examination of the inner structure of the composite microspheres by SEM indicated an interconnected porous structure that enabled nutrient transport (figures 1(C) and (D)). Due to the lack of cell attachment, cardiomyocytes could not survive in pure alginate microbeads. It was observed that most cardiomyocytes in pure alginate beads had round shape with no sign of attachment ( figure 2(A) ) and that, in contrast, cells in the composite beads spread in the beads ( figure 2(B) ). Furthermore, the cell viability was examined with trypan blue staining. The results obtained show that most cells were dead in pure alginate beads and that 85% cells remained viable in the composite beads. This suggests that the addition of collagen can substantially improve cell attachment. Cardiomyocyte growth in alginate/collagen composite beads was further examined in an extended time period. At day three, cardiomyocytes spread over the hydrogel as observed in figures 3(A) and (B) As time progressed, denser and larger cardiomyocyte aggregates were observed in the microbeads (figures 3(C) and (D)). After culturing for two months, cardiomyocytes entrapped in the microbeads formed densely EHT characterized by highly dense nuclei ( figure 3(E) ) and a multilayer F-actin structure ( figure 3(F) ). The distribution of the cells in the microbeads after encapsulation was even, as illustrated by DAPI-stained nuclei ( figure 4(A) ). After culturing for three weeks, the single cells proliferated and formed homogeneous tissue with cardiac tissue-like structures. The EHTs in the microbeads were visible with the naked eye ( figure 4(B) ), and the microbeads deformed with degradation (figures 4(C) and (D)). The constructs were stable in this 3D form for up to 180 days in culture. The majority (about 80%) of the cells expressed the musclespecific proteins sarcomeric tropomyosin and sarcomeric aactin ( figures 5(A)-(D) ), indicating that the cardiomyocytes had not been overgrown by fibroblasts.
To examine the cell distribution in the composite microbeads, the H&E images of the microbead slices were captured. It was observed that cells were distributed both near to the edge of the microbeads and at the center of the beads (figures 6(A) and (B)). To examine the focal adhesion formation, immunofluorescence staining was performed using an antibody of FAK, and FAKs around cardiomyocytes were clearly observed ( figure 6(C) ). Also, immunofluorescence staining was carried out using anti-fibronectin (one of the ECM proteins) to observe the fibronectin, which was found being distributed around cardiomyocytes ( figure 6(D) ). This suggested that the ECM protein synthesis was going well. SEM analysis of the EHT grafts showed a dense structure with several cell layers ( figures 7(A)-(D) ). The cell density was examined by counting the cell number after digesting the EHT into the single cell suspension, giving a value of about 5 × 107 cells cm −3 , which is at the same level as that of native heart tissue. The transmission electron micrographs of the constructs demonstrated the presence of well-organized myofilaments (Mfl) with equally spaced Z lines ( figure 8(A) ). Subcellular elements of cardiac myocytes were observed, including mitochondria ( figure 8(B) ) and endoplasmic reticulum ( figure 8(C) ); cell-to-cell connections were demonstrated by the presence of cell junctions between two cardiac myocytes ( figure 8(D) ).
The contractile state of the EHT grafts in calcium-and barium-cross-linked microbeads was monitored using digital video.
In the calcium-crosslinked beads, weak and unsynchronized contractions were observed initially (supplementary movie 1 available at stacks.iop.org/BMM/6/045002/mmedia), which, however, died away in two weeks. In contrast, the EHTs in bariumcross-linked microbeads were observed to beat with the microbead in a synchronized manner (supplementary movies 2 and 3 available at stacks.iop.org/BMM/6/045002/mmedia), suggesting that morphologic and electrical communication between the cells had been established. The beating of the EHT lasted for two months with a frequency of 20-30 beats min −1 ( figure 9 ).
Discussion
The in vitro fabrication of dense native heart-like tissue holds great promise not only for MI treatment but also as an in vitro experimental model for the study of acute ischemiainduced changes [39, 40] . Traditional scaffolds have not proven to be suitable for the fabrication of dense EHTs due to limited cell migration in the scaffold and restriction of nutrient transportation. Alginate is a negatively charged polymer and lacks cell-surface receptors for cell attachment. In contrast, collagen, a major component of ECM, has the ability to promote cell attachment and migration, and is thus suitable for cultivating the adherent cells. This study demonstrates the feasibility of forming dense EHT grafts in vitro by means of alginate/collagen composite microbeads. The small size of the microbeads faciliates rapid transport of nutrients by diffusion to cells at any location in the beads, thereby allowing the generation of modules with cell densities similar to those of native tissues (10 8 -10 9 cells cm −3 ) [41] . The degradation of scaffolds, once implanted, usually causes an inflammatory response. To address this problem, Shimizu et al [30] developed an approach whereby cell sheets are cultured using a temperature-sensitive polymer; cultured cells can be harvested as intact sheets as the temperature changes, thereby avoiding the use of proteolytic enzymes. Engineered cell sheets can be used in either direct transplantation to host tissues or for the creation of 3D layer structures to facilitate tissue regeneration. In our composite microbead model, the EHTs can be released as intact blocks without the use of proteolytic enzymes, which makes the implantation of EHTs without scaffolds possible. Compared with the thermosensitive polymer approach, cells harvested by this technique suffer much less damage. Alginate microbead encapsulation can provide a unique microenvironment modulating cell behaviors such as cell proliferation and differentiation.
For example, undifferentiated mouse embryonic stem cells (mESCs) encapsulated in 1.1% (w/v) alginate microbeads are able to differentiate into cystic embryoid bodies (EBs) and spontaneously beating cells [42] .
However, mESCs encapsulated in 1.6% (w/v) alginate result in inhibited differentiation at the morula-like stage without cystic EB formation. Human embryonic stem cells encapsulated in 1.1% (w/v) calcium alginate hydrogels remain undifferentiated for a period of up to 260 days in the basic maintenance medium [43] . Here we demonstrated that alginate/collagen microbeads encapsulating cardiomyocytes are able to form multiple-layered structures as required in the fabrication of EHT, indicating that the 3D microenvironment produced by the composite microbeads is favorable to cardiomyocyte growth.
Alginate beads are usually made by calcium ion cross-linking; however, cardiomyocytes are sensitive to the calcium ion [44] , which might impede contractile function.
Alginate microbeads cross-linked by barium ions have good microcapsule morphology, durability, and cellular viability [36] .
Inspired by this, we selected barium ions to cross-link the composite beads in this study. The EHTs fabricated in alginate-collagen composite microbeads contracted macroscopically in a synchronized manner during the study period, suggesting that barium ions do not interfere with the contractile function of cardiomyocytes.
Conclusion
We have demonstrated the feasibility of fabricating alginate/collagen composite microbeads by barium ion crosslinking and the encapsulation of cardiomyocytes in the composite microbeads. In doing so, we have established a promising approach for fabricating EHT grafts that can provide a heart-like microenvironment for cardiomyocytes, as applied to the treatment of cardiac infarction. The authors are currently pursuing in vivo studies on the fabricated EHT grafts.
